Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome

disease
On this page

Summary

Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome (MONDO:0012508) is a disease. A subtype of congenital agammaglobulinemia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 54

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families3WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

54 HPO clinical features (Orphanet curated; top 50 by frequency):

HPO IDTermFrequency
HP:0010976Decreased total B cell countVery frequent (80-99%)
HP:0000175Cleft palateFrequent (30-79%)
HP:0000252MicrocephalyFrequent (30-79%)
HP:0000347MicrognathiaFrequent (30-79%)
HP:0000369Low-set earsFrequent (30-79%)
HP:0000430Underdeveloped nasal alaeFrequent (30-79%)
HP:0000452Choanal stenosisFrequent (30-79%)
HP:0000581BlepharophimosisFrequent (30-79%)
HP:0001036ParakeratosisFrequent (30-79%)
HP:0001051Seborrheic dermatitisFrequent (30-79%)
HP:0001166ArachnodactylyFrequent (30-79%)
HP:0001263Global developmental delayFrequent (30-79%)
HP:0001508Failure to thriveFrequent (30-79%)
HP:0002098Respiratory distressFrequent (30-79%)
HP:0002850Decreased circulating total IgMFrequent (30-79%)
HP:0004440Coronal craniosynostosisFrequent (30-79%)
HP:0008897Postnatal growth retardationFrequent (30-79%)
HP:0011471Gastrostomy tube feeding in infancyFrequent (30-79%)
HP:0025092Epidermal acanthosisFrequent (30-79%)
HP:0031190Superficial dermal perivascular inflammatory infiltrateFrequent (30-79%)
HP:0000023Inguinal herniaOccasional (5-29%)
HP:0000028CryptorchidismOccasional (5-29%)
HP:0000054MicropenisOccasional (5-29%)
HP:0000126HydronephrosisOccasional (5-29%)
HP:0000160Narrow mouthOccasional (5-29%)
HP:0000244BrachyturricephalyOccasional (5-29%)
HP:0000278RetrognathiaOccasional (5-29%)
HP:0000286EpicanthusOccasional (5-29%)
HP:0000348High foreheadOccasional (5-29%)
HP:0000431Wide nasal bridgeOccasional (5-29%)
HP:0000494Downslanted palpebral fissuresOccasional (5-29%)
HP:0000883Thin ribsOccasional (5-29%)
HP:0000890Long claviclesOccasional (5-29%)
HP:0000954Single transverse palmar creaseOccasional (5-29%)
HP:0000964Eczematoid dermatitisOccasional (5-29%)
HP:0000989PruritusOccasional (5-29%)
HP:0001081CholelithiasisOccasional (5-29%)
HP:0001344Absent speechOccasional (5-29%)
HP:0001511Intrauterine growth retardationOccasional (5-29%)
HP:0001845Overlapping toeOccasional (5-29%)
HP:0002021Pyloric stenosisOccasional (5-29%)
HP:0002089Pulmonary hypoplasiaOccasional (5-29%)
HP:0002208Coarse hairOccasional (5-29%)
HP:0002240HepatomegalyOccasional (5-29%)
HP:0002506Diffuse cerebral atrophyOccasional (5-29%)
HP:0002594Pancreatic hypoplasiaOccasional (5-29%)
HP:0002949Fused cervical vertebraeOccasional (5-29%)
HP:0004425Flat foreheadOccasional (5-29%)
HP:0004616Cleft vertebral archOccasional (5-29%)
HP:0005365Severe B lymphocytopeniaOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical nameagammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome
Mondo IDMONDO:0012508
MeSHC538055
OMIM610483
Orphanet83617
SNOMED CT722281001
UMLSC1864848
MedGen351236
GARD0010011
Is cancer (heuristic)no

Disease family

This is a subtype of congenital agammaglobulinemia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › hematologic disorder › congenital hematological disorder › congenital agammaglobulinemiaagammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome

Related subtypes (1): short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.